Big Pharma achieves total legal immunity for coronavirus vaccines; even as vaccine injections will be FORCED onto billions of people, potentially killing tens of millions

(Natural News) We have now arrived at the ultimate moneymaking scam for Big Pharma, a corrupt, criminal industry that’s going to great lengths to pressure Big Tech to censor all speech that doesn’t earn them more profits. Now, vaccine manufacturers like AstraZeneca are openly bragging about how they’ve achieved absolute legal immunity from all side...
Source: - Category: Consumer Health News Source Type: news

Related Links:

Authors: Madubueze CE, Dachollom S, Onwubuya IO Abstract Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). It was declared on March 11, 2020, by the World Health Organization as pandemic disease. The disease has neither approved medicine nor vaccine and has made governments and scholars search for drastic measures in combating the pandemic. Regrettably, the spread of the virus and mortality due to COVID-19 has continued to increase daily. Hence, it is imperative to control the spread of the disease particularly using nonpharmacological strategie...
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Tags: Comput Math Methods Med Source Type: research
Authors: Chukwudozie OS, Chukwuanukwu RC, Iroanya OO, Eze DM, Duru VC, Dele-Alimi TO, Kehinde BD, Bankole TT, Obi PC, Okinedo EU Abstract The novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has previously never been identified with humans, thereby creating devastation in public health. The need for an effective vaccine to curb this pandemic cannot be overemphasized. In view of this, we designed a subcomponent antigenic peptide vaccine targeting the N-terminal (NT) and C-terminal (CT) RNA binding domains of the nucleocapsid protein that aid in viral replica...
Source: Journal of Immunology Research - Category: Allergy & Immunology Tags: J Immunol Res Source Type: research
College enrollment has shown signs of a decline — and in some unexpected ways. New York State plans its own review of vaccines amid concern that the U.S. approval process has become politicized.
Source: NYT Health - Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news
Novavax received $1.6 billion from the U.S. federal government to fund the late-stage development and production of its vaccine.
Source: Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Billionaires Source Type: news
The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Novavax Inc Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Johnson & Moderna Inc Pfizer Inc Research Influenza Drugs (Pharmaceuticals) Great Britain United States Source Type: news
The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
When a contagious, deadly pandemic sweeps around the globe, people look to the World Health Organization (WHO) for guidance. It’s not easy to be the person in charge under those circumstances, but as director-general of the WHO, Dr. Tedros Adhanom Ghebreyesus has led the way. Tedros, as he likes to be called, is one of the TIME100 honorees for 2020. During a TIME100 Talks interview with Senior Correspondent Alice Park, he discussed the WHO’s response to the coronavirus pandemic and the dangers of politicizing a virus that knows no boundaries. March 11, 2020—the day the WHO declared COVID-19 a pandemic&mda...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
A Chinese pharmaceutical company says its coronavirus vaccine candidate will be ready for the world by early next year
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Authors: Mukherjee S, Ray SK Abstract Coronavirus disease is a potentially deadly disease and of significant apprehension for global communal health potentially because of its lethality. Vaccines and antiviral medications are still under trial to prevent or treat infections of human coronavirus (HCoV) till date. The virus HCoV originate in 2003, SARS-CoV, which causes respiratory syndrome having distinctive pathogenesis and causes infections of the respiratory tract. A mechanism was projected for the evolution of SARS virus and a handy association with bats was found. When this virus reaches respective host system,...
Source: Recent Patents on Anti-Infective Drug Discovery - Category: Infectious Diseases Tags: Recent Pat Antiinfect Drug Discov Source Type: research
CONCLUSIONS: SARS-CoV-2 is a novel coronavirus that has caused a global pandemic. We should pay more attention to prevent SARS-CoV-2 and try to control it sooner. PMID: 32965016 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: AstraZeneca | Coronavirus | COVID-19 | Health | Legislation | Pharmaceuticals | Vaccines